These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4098767)

  • 41. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Haematologica; 1985; 70(3):269-70. PubMed ID: 3932161
    [No Abstract]   [Full Text] [Related]  

  • 42. Heparin-induced inhibitory effects of a prothrombin complex concentrate on global tests of haemostasis.
    Takeyama M; Sakurai Y; Shima M; Matsumoto T; Nogami K; Tanaka I; Takeda T; Giddings JC; Yoshioka A
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):1-7. PubMed ID: 17179819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticoagulant proteins in childhood venous and arterial thrombosis: a review.
    Segel GB; Francis CA
    Blood Cells Mol Dis; 2000 Oct; 26(5):540-60. PubMed ID: 11112387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
    [No Abstract]   [Full Text] [Related]  

  • 45. [MYOCARDIAL INFARCT AND THROMBOSIS IN PRACTICE. AMBULANT ANTICOAGULANT THERAPY AND CONTROL OF DEVELOPMENTS. CENTRAL THROMBOSIS SERVICES].
    EDAM K
    Med Welt; 1964 Apr; 16():910-5. PubMed ID: 14196333
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical coagulation laboratory and oral anticoagulant therapy treatment. Instrumentation and methodology.
    Barbui T; Finazzi G; Remuzzi A
    Thromb Haemost; 1995 Jul; 74(1):511-4. PubMed ID: 8578515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of thrombosis during pregnancy.
    Inbal A
    Isr Med Assoc J; 2002 Oct; 4(10):813-4. PubMed ID: 12389348
    [No Abstract]   [Full Text] [Related]  

  • 48. Symposium. Standardizing the control of oral anticoagulant treatment.
    Ingram GI
    Thromb Diath Haemorrh; 1975 Apr; 33(2):142-7. PubMed ID: 1138410
    [No Abstract]   [Full Text] [Related]  

  • 49. [Anticoagulant therapy in cardiovascular diseases. II. Clinical problems of anticoagulant therapy].
    Latallo ZS; Malanowicz W
    Kardiol Pol; 1971; 14(1):99-107. PubMed ID: 5552716
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of various laboratory tests in the control of anticoagulant therapy].
    Molinas FC; Sanchez Avalos JC
    Medicina (B Aires); 1967; 27(2):107-15. PubMed ID: 5600645
    [No Abstract]   [Full Text] [Related]  

  • 51. [Slope of decrease of coagulation factors during anticoagulant therapy (tioclomarol) (author's transl)].
    Valty J; Dumoulin P; Vergoz D; Rozenstajn L; Ferrer F; Jaillon P
    Therapie; 1980; 35(5):613-8. PubMed ID: 7209858
    [No Abstract]   [Full Text] [Related]  

  • 52. [Basic principles anticoagulant therapy].
    Mammen EF
    Internist (Berl); 1969 Jan; 10(1):2-8. PubMed ID: 4190310
    [No Abstract]   [Full Text] [Related]  

  • 53. [Report on the experience with long-term anticoagulant treatment].
    Egli H
    Thromb Diath Haemorrh Suppl; 1964; 12():89-92. PubMed ID: 5882983
    [No Abstract]   [Full Text] [Related]  

  • 54. [Metabolism of a derivative of 4-hydroxy-coumarin: 3(alfa-acetonyl-p-nitrobenzyl)4-hydroxy-coumarin (Sintrom) in man].
    Blatrix C; Charonnat S; Tillement JP; Israel J; Brevet JP; Debraux J; Merlin M
    Rev Fr Etud Clin Biol; 1968 Dec; 13(10):984-95. PubMed ID: 4185223
    [No Abstract]   [Full Text] [Related]  

  • 55. [Recommendation of the Group for Studies on Hemostasis and Thrombosis. Toward better supervision of anticoagulant therapy by anti-vitamin K agents].
    Pathol Biol (Paris); 1986 Nov; 34(9):1035-6. PubMed ID: 3543814
    [No Abstract]   [Full Text] [Related]  

  • 56. [New aspects of jaw surgery under anticoagulant treatment with planned substitution therapy].
    Büning K; Dieckmann J; Hackmann G
    Dtsch Zahnarztl Z; 1976 Aug; 31(8):654-6. PubMed ID: 1066247
    [No Abstract]   [Full Text] [Related]  

  • 57. Guidelines on the use and monitoring of heparin.
    Baglin T; Barrowcliffe TW; Cohen A; Greaves M;
    Br J Haematol; 2006 Apr; 133(1):19-34. PubMed ID: 16512825
    [No Abstract]   [Full Text] [Related]  

  • 58. Phleboembolism in orthopaedic trauma.
    Olwin JH; Koppel JL
    Clin Orthop Relat Res; 1963; 28():89-94. PubMed ID: 5889045
    [No Abstract]   [Full Text] [Related]  

  • 59. [Anticoagulants].
    Coelho E
    Rev Hosp Clin Fac Med Sao Paulo; 1968 Jul; 23(4):217-28. PubMed ID: 4175980
    [No Abstract]   [Full Text] [Related]  

  • 60. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.